HomeInsightsResults

Jenburkt Pharmaceuticals Ltd Quarterly Result

Jenburkt Pharmaceuticals Ltd Quarterly Result

stocks purchased

₹ 0.2 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

1.4 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 27, 2024

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

Net Profit

₹ 9.6

Last updated on: Dec 27, 2024

Key Highlights

  • The revenue of Jenburkt Pharmaceuticals Ltd for the Sep '24 is ₹ 43.07 crore as compare to the Jun '24 revenue of ₹ 33.94 crore. This represent the growth of 26.900417%.
  • The ebitda of Jenburkt Pharmaceuticals Ltd for the Sep '24 is ₹ 13.28 crore as compare to the Jun '24 ebitda of ₹ 10.7 crore. This represent the growth of 24.11215%.
  • The net profit of Jenburkt Pharmaceuticals Ltd for the Sep '24 is ₹ 9.6 crore as compare to the Jun '24 net profit of ₹ 7.42 crore. This represent the growth of 29.380058%.

Results Analysis

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Dec 20241187
26 Dec 20241201.05
24 Dec 20241213.55
23 Dec 20241218
20 Dec 20241242.4
19 Dec 20241290.5
18 Dec 20241314.7
17 Dec 20241326.7
16 Dec 20241303.7
13 Dec 20241312.3

Historical Revenue of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Jenburkt Pharmaceuticals Ltd News Hub

News

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5...

Read more

29 Oct 2024 15:24

News

Jenburkt Pharmaceuticals to declare Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

19 Jul 2024 10:24

News

Jenburkt Pharmaceuticals to conduct AGM

Jenburkt Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa...

Read more

24 Jun 2024 09:36

News

Board of Jenburkt Pharmaceuticals recommends final dividend

Jenburkt Pharmaceuticals announced that the Board of Directors of the Company at its meeti...

Read more

29 May 2024 10:57

News

Jenburkt Pharmaceuticals schedules board meeting

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

21 May 2024 15:36

News

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6...

Read more

20 Jan 2024 12:45

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Jenburkt Pharmaceuticals Ltd

What key financial metrics are included in Jenburkt Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Jenburkt Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Jenburkt Pharmaceuticals Ltd announce its quarterly results?

Jenburkt Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Jenburkt Pharmaceuticals Ltd's quarterly performance impact its stock price?

Jenburkt Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Jenburkt Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Jenburkt Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Jenburkt Pharmaceuticals Ltd's quarterly results?

Yes, Jenburkt Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions